Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is March - February.

Millions USD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 1, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	2017 - 2021
Market Capitalization	62	63	153	602	523	300	Upgrade
Market Cap Growth	-63.65%	-58.68%	-74.54%	15.10%	74.69%	2012.88%	Upgrade
Enterprise Value	58	60	138	590	478	296	Upgrade
Last Close Price	0.28	0.29	0.69	2.82	2.58	2.43	Upgrade
PB Ratio	0.55	0.60	1.23	4.26	3.48	24.34	Upgrade
P/TBV Ratio	0.55	0.60	1.23	4.26	3.48	24.34	Upgrade
Debt / Equity Ratio	0	0.00	0.00	0.00	0.01	0.07	Upgrade
Quick Ratio	1.19	0.45	5.44	23.59	30.09	7.16	Upgrade
Current Ratio	1.48	0.74	6.24	24.81	30.58	7.24	Upgrade
Return on Equity (ROE)	-9.65%	-15.56%	-22.06%	-18.62%	-22.81%	-155.76%	Upgrade
Return on Assets (ROA)	-6.22%	-8.16%	-13.51%	-11.54%	-13.66%	-85.02%	Upgrade
Return on Capital (ROIC)	-6.36%	-8.39%	-13.73%	-11.63%	-13.79%	-89.94%	Upgrade
Earnings Yield	-18.16%	-27.33%	-19.16%	-4.35%	-3.55%	-3.41%	Upgrade
FCF Yield	-10.78%	-11.83%	-11.50%	-3.54%	-2.07%	-2.54%	Upgrade
Buyback Yield / Dilution	-1.47%	-1.52%	-3.36%	-17.57%	-68.36%	-58.37%	Upgrade

Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.